PCE

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

NP course advisor: Nana Bernasko, DNP, CRNP, WHNP-BC, Penn State University Medical Center, Hershey, Pennsylvania

Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until July 28, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Richard H. Davis, PA-C, University of Florida College of Medicine, Gainesville, Florida

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

This activity is supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.

This activity is supported by educational grants from Amgen; and Ferring Pharmaceuticals, Inc.

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Anita Afzali, MD, MPH, MHCM, FACG, AGAF: consultant/advisor/speaker: AbbVie, DiaSorin, Eli Lilly, Gilead, Janssen, Pfizer, Takeda, TLL Pharmaceuticals.

Nana Bernasko, DNP, CRNP, WHNP-BC: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, Eli Lilly, Janssen.

Richard H. Davis, PA-C, has no relevant financial relationships to disclose.

None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose, except Nana Bernasko, DNP, CRNP, WHNP-BC as noted above.

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.

The estimated time to complete this activity is 0.25 hours.

Release date: July 29, 2022
Expiration date: July 28, 2023

For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.